Related Experiment Video
Updated: Dec 3, 2025

05:34
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
Published on: September 8, 2023
1.1K
opvCRISPR: One-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection
Rui Wang1, Chunyan Qian2, Yanan Pang3
1Department of Chemistry & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, 200433, PR China.
Biosensors & Bioelectronics
|October 30, 2020
Summary
A novel one-pot visual detection system, opvCRISPR, rapidly identifies SARS-CoV-2 using RT-LAMP and Cas12a. This sensitive method offers naked-eye detection and 100% agreement with RT-PCR for COVID-19 diagnostics.
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- The COVID-19 pandemic necessitates rapid, sensitive, and user-friendly SARS-CoV-2 detection methods.
- Existing diagnostic tools require optimization for point-of-care applications and early intervention.
Purpose of the Study:
- To develop a novel, integrated system for visual detection of SARS-CoV-2.
- To enhance sensitivity and speed for molecular diagnostics of COVID-19.
Main Methods:
- Integration of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and Cas12a cleavage in a one-pot system (opvCRISPR).
- Utilizing Cas12a's collateral activity on single-stranded DNA (ssDNA) reporters for visual signal generation.
- Validation using 50 potentially infected clinical samples and comparison with CDC-approved quantitative RT-PCR.
Main Results:
- The opvCRISPR system achieved nearly single-molecule detection sensitivity within 45 minutes.
- Visual detection of SARS-CoV-2 was enabled by the amplified RT-LAMP product triggering Cas12a activity.
- opvCRISPR demonstrated 100% agreement with quantitative RT-PCR results.
Conclusions:
- opvCRISPR offers a rapid, sensitive, and visual method for SARS-CoV-2 detection.
- The system shows significant potential for next-generation point-of-care molecular diagnostics.
- This approach facilitates early intervention and control of SARS-CoV-2 spread.

